Table 1.
List of metabolites with significant changes in the experimental treatments (p ≤ 0.01)
| Compound | Ambient | Elevated [CO2] | Elevated Temperature | Combination | |||
|---|---|---|---|---|---|---|---|
| Log2(x̃) ± SE | Log2(x̃) ± SE | Log2(FC) | Log2(x̃) ± SE | Log2(FC) | Log2(x̃) ± SE | Log2(FC) | |
| 1,3-Diaminopropane | 9.21 ± 0.27 | 9.81 ± 0.23 | 0.60 | 10.91 ± 0.13 | 1.70 | 9.95 ± 0.24 | 0.75 |
| 1-Benzylglucopyranoside | 9.61 ± 0.21 | 10.56 ± 0.17 | 0.95 | 10.89 ± 0.26 | 1.28 | 10.76 ± 0.15 | 1.15 |
| 2-Methylmalic acid | 11.27 ± 0.48 | 8.25 ± 0.17 | − 3.02 | 9.60 ± 0.17 | − 1.67 | 10.30 ± 0.38 | − 0.97 |
| α-ketoglutaric acid | 9.93 ± 0.33 | 7.78 ± 0.21 | − 2.15 | 10.57 ± 0.25 | 0.63 | 9.21 ± 0.25 | − 0.72 |
| α-tocopherol | 10.85 ± 0.23 | 11.44 ± 0.23 | 0.59 | 12.25 ± 0.30 | 1.41 | 12.43 ± 0.16 | 1.58 |
| γ-tocopherol | 8.48 ± 0.17 | 8.90 ± 0.14 | 0.42 | 9.12 ± 0.18 | 0.64 | 8.26 ± 0.12 | − 0.22 |
| Arabinose | 12.68 ± 0.12 | 13.21 ± 0.17 | 0.52 | 13.92 ± 0.25 | 1.24 | 13.34 ± 0.25 | 0.65 |
| Arabitol | 10.90 ± 0.22 | 11.61 ± 0.26* | 0.71 | 11.67 ± 0.14 | 0.77 | 11.02 ± 0.16 | 0.12 |
| Dehydroascorbic acid | 11.54 ± 0.21 | 11.81 ± 0.14 | 0.27 | 12.57 ± 0.15 | 1.02 | 11.71 ± 0.19 | 0.17 |
| Ethanolamine | 14.58 ± 0.15 | 15.07 ± 0.13* | 0.49 | 15.23 ± 0.11 | 0.65 | 14.70 ± 0.16 | 0.12 |
| Fructose | 20.19 ± 0.19 | 20.57 ± 0.21 | 0.38 | 21.27 ± 0.11 | 1.08 | 20.38 ± 0.23 | 0.19 |
| Galactose | 15.85 ± 0.18 | 16.71 ± 0.21 | 0.87 | 16.88 ± 0.18 | 1.03 | 16.22 ± 0.20 | 0.37 |
| Gluconic acid | 10.03 ± 0.05 | 10.68 ± 0.23 | 0.65 | 10.98 ± 0.17 | 0.95 | 10.77 ± 0.20 | 0.74 |
| Glucose | 20.55 ± 0.08 | 21.10 ± 0.21* | 0.55 | 21.47 ± 0.09 | 0.92 | 20.54 ± 0.23 | − 0.01 |
| Glyceric acid | 16.47 ± 0.12 | 17.20 ± 0.09 | 0.72 | 17.25 ± 0.15 | 0.78 | 16.54 ± 0.20 | 0.07 |
| Inositol | 14.78 ± 0.18 | 15.50 ± 0.19 | 0.71 | 15.83 ± 0.15 | 1.05 | 15.47 ± 0.16 | 0.68 |
| Isoleucine | 9.59 ± 0.17 | 10.40 ± 0.25 | 0.81 | 10.75 ± 0.22 | 1.16 | 10.58 ± 0.25 | 0.98 |
| Leucine | 9.45 ± 0.33 | 10.11 ± 0.11 | 0.66 | 10.95 ± 0.39 | 1.50 | 10.44 ± 0.35 | 0.98 |
| Maltose | 15.06 ± 0.15 | 15.50 ± 0.14 | 0.44 | 15.74 ± 0.07 | 0.68 | 14.98 ± 0.26 | − 0.08 |
| Melibiose | 11.08 ± 0.23 | 11.91 ± 0.19 | 0.84 | 13.02 ± 0.27 | 1.94 | 12.24 ± 0.37 | 1.17 |
| Neochlorogenic acid | 16.72 ± 0.21 | 16.96 ± 0.11 | 0.24 | 17.32 ± 0.14 | 0.60 | 17.17 ± 0.13 | 0.45 |
| O-acetylsalicylic acid | 10.73 ± 0.11 | 11.00 ± 0.12 | 0.27 | 11.79 ± 0.19 | 1.06 | 11.09 ± 0.22 | 0.36 |
| Oxalic acid | 13.46 ± 0.16 | 13.54 ± 0.15 | 0.08 | 11.92 ± 0.31 | − 1.54 | 12.04 ± 0.31 | − 1.42 |
| Phenylalanine | 9.49 ± 0.13 | 9.83 ± 0.21 | 0.34 | 10.76 ± 0.36 | 1.27 | 10.81 ± 0.40 | 1.31 |
| Quinic acid | 17.30 ± 0.22 | 18.22 ± 0.12 | 0.92 | 18.14 ± 0.12 | 0.84 | 17.68 ± 0.13 | 0.39 |
| Ribitiol | 10.25 ± 0.25 | 10.81 ± 0.17 | 0.55 | 11.57 ± 0.21 | 1.32 | 10.90 ± 0.22* | 0.64 |
| Ribose | 14.92 ± 0.17 | 15.25 ± 0.10 | 0.33 | 15.56 ± 0.12 | 0.64 | 15.13 ± 0.18 | 0.21 |
| Serine | 14.04 ± 0.11 | 13.92 ± 0.11 | − 0.12 | 15.15 ± 0.16 | 1.11 | 14.36 ± 0.26 | 0.32 |
| Sinapic acid | 7.30 ± 0.19 | 7.74 ± 0.15 | 0.45 | 7.99 ± 0.20 | 0.69 | 7.98 ± 0.18 | 0.69 |
| Stigmasterol | 11.52 ± 0.14 | 12.14 ± 0.25 | 0.62 | 12.75 ± 0.22 | 1.23 | 12.65 ± 0.15* | 1.13 |
| Threitol | 8.97 ± 0.12 | 9.28 ± 0.09 | 0.31 | 10.23 ± 0.15 | 1.26 | 9.78 ± 0.16 | 0.81 |
| Threonine | 11.90 ± 0.29 | 12.38 ± 0.11 | 0.46 | 13.30 ± 0.12 | 1.38 | 12.77 ± 0.26 | 0.85 |
| Valine | 10.57 ± 0.40 | 11.19 ± 0.15* | 0.61 | 12.22 ± 0.18 | 1.64 | 11.91 ± 0.26 | 1.34 |
| Xylose | 8.80 ± 0.20 | 9.71 ± 0.15* | 0.91 | 10.26 ± 0.26 | 1.46 | 10.08 ± 0.26 | 1.27 |
The log2 normalized median values ± standard error and log2fold change (log2(FC)) for each treatment are shown. Metabolites significantly changed are denoted by bold value (p ≤ 0.01) or *(p ≤ 0.05). Bold italic cells show increased metabolite content and italics represents decreased metabolite content in the treatments